|
Issue |
Title |
|
Vol 16, No 4 (2020) |
Resolution of the Expert Council “Current approaches to pharmacotherapy of non-metastatic castration-resistant prostate cancer” |
Abstract
PDF (Rus)
|
article Editorial |
|
Vol 16, No 3 (2020) |
Advisory Council on combined immunochemotherapy for urothelial cancer |
Abstract
PDF (Rus)
|
article Editorial |
|
Vol 15, No 4 (2019) |
In Russia, a new indication for pembrolizumab in combination with axitinib in the first-line treatment of patients with advanced renal cell carcinoma has been approved |
Abstract
PDF (Rus)
|
Article Editorial |
|
Vol 15, No 3 (2019) |
Tactics of vinflunin therapy; determining the best supportive treatment for malignant neoplasms of the bladder, on a stage III–IV |
Abstract
PDF (Rus)
|
Article Editorial |
|
Vol 15, No 2 (2019) |
Immunotherapy advisory council for urothelial cancer |
Abstract
PDF (Rus)
|
Article Editorial |
|
Vol 15, No 2 (2019) |
Resolution on the results of the Expert Council on the treatment of advanced and metastatic clear cell renal cell carcinoma |
Abstract
PDF (Rus)
|
Article Editorial |
|
Vol 13, No 1 (2017) |
Current treatment options for advanced renal-cell carcinoma: Decision of the Expert Board |
Abstract
PDF (Rus)
|
Б. Я. Алексеев, , , , , , , , , , , , , , |
|
Vol 13, No 1 (2017) |
Discussion on problems of prostate cancer treatment and the role of cabazitaxel in treatment of patients with metastatic castration-resistant prostate cancer: Decision of the Expert Board |
Abstract
PDF (Rus)
|
, , , , , , , , , , , , , , , |
|
1 - 8 of 8 Items |
|